Long-term control by immune checkpoint inhibitors in a lung cancer patient with chronic kidney disease
{{output}}
Background: Immune checkpoint inhibitor (ICI) therapy has brought about a revolutionary advance in the treatment of advanced non-small cell lung cancer (NSCLC). Not a few patients with NSCLC have comorbid diseases. In patients wh... ...
